| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―05 |
The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells |
Emma Lee Johnson, Yuki Ohkawa, Noriko Kanto, Reiko Fujinawa, Taiki Kuribara, Eiji Miyoshi, Naoyuki Taniguchi |
| 2 |
[GO] |
2023―Nov―15 |
Heat shock protein 27 in the pathogenesis of COVID-19 and non-COVID acute respiratory distress syndrome |
Michael H. Chiu, Benjamin Gershkovich, Ian-Ling Yu, Edward R. O’Brien, Jingti Deng, Braedon McDonald |
| 3 |
[GO] |
2023―Oct―05 |
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway |
Rabab S. Hamad, Hayder M. Al-kuraishy, Athanasios Alexiou, Marios Papadakis, Eman A. Ahmed, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 4 |
[GO] |
2023―Feb―17 |
Investigation of inflammation, oxidative stress, and DNA damage in COVID-19 patients |
Muhammet Yusuf Tepebaşı, İlter İlhan, Esra Nurlu Temel, Okan Sancer, Önder Öztürk |
| 5 |
[GO] |
2023―Feb―08 |
Hippo-YAP signaling and SARS-CoV-2 infection: a new mechanistic pathway |
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 6 |
[GO] |
2022―Nov―23 |
Transcription factor Nrf2 as a potential therapeutic target for COVID-19 |
Yifan Wang, Jing Ma, Yongfang Jiang |
| 7 |
[GO] |
2021―Nov―30 |
Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19 |
Philip L. Hooper |
| 8 |
[GO] |
2021―Nov―09 |
Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19? |
Paola Finotti |
| 9 |
[GO] |
2021―Aug―12 |
Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies |
Andrii Puzyrenko, Elizabeth R. Jacobs, Yunguang Sun, Juan C. Felix, Yuri Sheinin, Linna Ge, Shuping Lai, Qiang Dai, Benjamin N. Gantner, Rahul Nanchal, Paula E. North, Pippa M. Simpson, Hallgeir Rui, Ivor J. Benjamin |
| 10 |
[GO] |
2021―May―11 |
SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity |
Stefano Burgio, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello |
| 11 |
[GO] |
2021―Feb―24 |
CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients |
M. Hernandez-Cedeño, R. Venegas-Rodriguez, R. Peña-Ruiz, M. Bequet-Romero, R. Santana-Sanchez, E. Penton-Arias, G. Martinez-Donato, G. Guillén-Nieto, María del Carmen Dominguez-Horta |
| 12 |
[GO] |
2021―Jan―05 |
Stress proteins as predictors of COVID-19 outcomes |
Barry G. Hall |
| 13 |
[GO] |
2020―Nov―16 |
Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention |
Michael Kasperkiewicz |
| 14 |
[GO] |
2020―Sep―05 |
Coronaviruses and stress: from cellular to global |
Lawrence E. Hightower, M. Gabriella Santoro |
| 15 |
[GO] |
2020―Aug―06 |
Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
Edward R. O’Brien, Jagdeep K. Sandhu |
| 16 |
[GO] |
2020―Aug―04 |
Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19 |
Antonella Marino Gammazza, Sébastien Légaré, Giosuè Lo Bosco, Alberto Fucarino, Francesca Angileri, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello |
| 17 |
[GO] |
2020―Jul―29 |
SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism |
Guglielmo Lucchese, Agnes Flöel |
| 18 |
[GO] |
2020―Jun―29 |
Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies |
Philip L. Hooper |
| 19 |
[GO] |
2020―Jun―04 |
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies |
Philip L. Hooper |
| 20 |
[GO] |
2020―Jun―02 |
COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? |
Antonio De Maio, Lawrence E. Hightower |
| 21 |
[GO] |
2020―May―26 |
On barring the vascular gateway against severe COVID-19 disease |
George Perdrizet, Lawrence E. Hightower |
| 22 |
[GO] |
2020―May―14 |
Possible application of H2S-producing compounds in therapy of coronavirus (COVID-19) infection and pneumonia |
Mikhail B. Evgen’ev, Anton Frenkel |
| 23 |
[GO] |
2020―Apr―20 |
Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
Francesco Cappello |
